NEWPORT PREMIUm

(FOR GENERICS)

Powerful integrated API intelligence with unique analysis

CONSOLIDATED DATA ON GENERICS

WHO CAN BENEFIT

Patent expiration
Paragraph IV data
Patent constraints
Market size
Sales volume, consumption and pricing
Market leads for potential partners/acquisition
targets
Region-specific data
Competitor intelligence

Newport Premium(for Generics) is the most advanced

product targeting, global business development and
API sourcing system from the industry authority on the
global generics market.
Created specifically for demanding professionals in
generic pharmaceutical companies, OTC and API
manufacturers, it can help you to identify and evaluate
new product development and licensing opportunities
ahead of the competition.

North America
Philadelphia +1 800 336 4474

+1 215 386 0100

Strategic planning
Business development
Product development
API sourcing and sales
Product intelligence
Company intelligence

Latin America

+55 11 8370 9845
Europe, Middle East and Africa
London
+44 20 7433 4000
Asia Pacific
Singapore
+65 6775 5088
Tokyo
+81 3 5218 6500

STRATEGIC PLANNING

FIND THE OPPORTUNITY. MAKE THE DEAL.

GET TO MARKET

THOMSON REUTERS
REGIONAL OFFICES

Evaluate new product development

opportunities in over 70 markets worldwide
including India and China

For a complete office list visit:

science.thomsonreuters.com/contact

Identify niche opportunities that match your

strategic needs and unique research, sales or
marketing strengths
Adjust your research timing, priorities and
resources based on active competitive
intelligence monitoring

LS 201209
1004542

Copyright 2013 Thomson Reuters

Unique strategic intelligence and powerful

competitive analysis.
It integrates intelligence on more than 60,000
launched products containing over 10,000 different
active ingredients and over 30,000 corporate groups.
With its sophisticated targeting capabilities, Newport
Premium (for Generics) can help you indentify
promising new partner companies and secure early,
exclusive sources of API supply. API consumption
data and trends can be included in product-targeting
searches, enabling you to find the most appropriate
business opportunities quickly and accurately.
Test and explore new business strategies, recognize
potential barriers to market entry, and plan your
development pipeline effectively. With the industrys
most sophisticated product targeting capabilities, it
can significantly enhance your competitive edge.

Weekly alerting on
commentaries covering
paragraph IV patent challenges
on several hundred products

Product profile pages summarize

all key product-related data,
from sales to exclusivities

Target products using over

40 different criteria, covering
patents, product characteristics,
sales trends, and active
ingredient availability

Newport Premium (for Generics)

BUSINESS DEVELOPMENT

Profile competitors, business partners, and

candidate products for acquisition, alliances,
licensing, or supply and manufacturing
Track and monitor the launch, API development
and patenting activities of competitors worldwide,
including India and China
Evaluate candidate products against the earliest
competitive intelligence

API SOURCING AND SALES

Recognize critical patent, exclusivity and

regulatory issues with candidate products

Analyze and compare API consumption data and

trends by region, and by dose form for the current
and previous year

Discover early, exclusive sources of API supply

Analyze routes of synthesis together with required

intermediates and reagents, in addition to the
referenced patents and scientific literature

Chemical structure diagrams for thousands of

products

Routes of synthesis, including intermediates and

reagents with patent and literature references for
over 3,000 products

Powerful indexing and searching of products

according to FDA approved indication and
technology class

Proprietary analytics

GMP Certifications by ANVISA & WHO

US DMF Generic Drug User Fee reference status

COMPANY INTELLIGENCE

Competitor profiles of over 50,000 companies

and corporate groups, including subsidiaries,
finished dose launches, US approvals, regulatory
filings, APIs manufactured, inspections by the US
FDA and other regulatory agencies and Warning
Letters

Detailed manufacturing capabilities for over 1,200

API and biologic manufacturing sites and more
than 600 contract dose manufacturing sites.

PRODUCT INTELLIGENCE

Market size and sales volume data

Unique, early API manufacturing intelligence for

10,000 active ingredients

Company key financial indicators and sales

forecasts

Regulatory filings, such as US, Japanese and

Korean DMFs, Certificates of Suitability, Indian
and Chinese Import Registrations and US DEA
registration notices

Proprietary company ratings

Two years of regional sales and consumption

data, worldwide launch, and pack price data
for 60,000 launched products containing over
10,000 different active ingredients

US market share breakdown by dose form and

strength

US Orange Book, EU centralized procedure, and

European first market authorization data

PATENTS

Worldwide patent families and individual patents

for more than 90 countries

Comprehensive Supplementary Protection

Certificate (SPC) data for Europe

Projected loss of exclusivity dates for US,

European, Japanese and South Korean markets

Paragraph IV patent challenges commentaries,

including company identities, FTF and status of
litigation for more than 400 products.

CURRENT AWARENESS

See which manufacturers

are involved in producing or
developing a particular API and
what stage they have reached

E-mail alerting on key changes in products and

companies, including new regulatory filings,
approvals, and patent challenges

Real-time news regarding products and

companies

Reports on key conferences covering the generics

industry

LEARN more
To learn more about Newport Premium (for Generics), including the additional modules for Phase III drugs,
Generic industry deals (including mergers and acquisitions), US Market Shares, and Biologics, visit
go.thomsonreuters.com/newport.